Richfield (India) Pharmaceuiticals Private Limited - Company Profile

It is a pharma private limited company based in Hubballi, Karnataka, India, established in 2005.
2005 Hubballi, Karnataka, India Active
Last Updated:
Access Report
About Richfield (India) Pharmaceuiticals Private Limited

Richfield (India) Pharmaceuiticals Private Limited, a active private limited company, was established on 12 December 2005 in Hubballi, Karnataka, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U85110KA2005PTC037914. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹0.95 M and a paid-up capital of ₹0.91 M.

It upholds a compliant status. Employing 28 professional, Its leadership includes Laxmilal Bhavarlal Jain (Managing Director), Nisha Suman Jain (Director), Manjudevi Jain Laxmilal (Director). Past directors included Pralhad Bhimarao Gunari, Suvarna Gunari. It holds ₹1.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No.102, Cts No. 420/3A, First Floor Enkay Complex, Keshwapur, Hubballi, Karnataka, 580023.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85110KA2005PTC037914

  • Registration Number

    037914

  • Incorporation Date

    12 December 2005

  • Authorized Capital

    ₹0.95 M

  • Paid-Up Capital

    ₹0.91 M

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.95 M
  • Paid Up Capital ₹ 0.91 M
  • Company Age 20 Year, 2 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 1.00 Cr
  • Revenue Growth **** -12.75%
  • Profit Growth **** -15.94%
  • Ebitda **** -11.63%
  • Net Worth 33.61%
  • Total Assets **** 8.22%
Company report

Richfield (India) Pharmaceuiticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Richfield (India) Pharmaceuiticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Richfield (India) Pharmaceuiticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Laxmilal Bhavarlal Jain Managing Director 29 Aug 2007 Current
Nisha Suman Jain Director 27 Dec 2005 Current
Manjudevi Jain Laxmilal Director 12 Dec 2005 Current
Suman Laxmilal Jain Whole-Time Director 29 Aug 2007 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 29 Aug 2007 Past
Pramod Abcsdd Director 29 Aug 2007 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Richfield (India) Pharmaceuiticals.

Richfield (India) Pharmaceuiticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 12.75% decrease. The company also saw a substantial fall in profitability, with a 15.94% decrease in profit. The company's net worth Soared by an impressive increase of 33.61%.

Richfield (India) Pharmaceuiticals revenue growth over time
Richfield (India) Pharmaceuiticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -12.75%
*******
*******
*******
*******
Revenue from Operations
*******
 -12.94%
*******
*******
*******
*******
Total Assets
*******
 8.22%
*******
*******
*******
*******
Profit or Loss
*******
 -15.94%
*******
*******
*******
*******
Net Worth
*******
 33.61%
*******
*******
*******
*******
EBITDA
*******
 -11.63%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Richfield (India) Pharmaceuiticals?

In 2023, Richfield (India) Pharmaceuiticals had a public holding of 1.32%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹10,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 0.60 Cr
  • The United Western Bank Limited : 0.40 Cr
Latest Charge Details
Date Lender Amount Status
15 Sep 2017 Others ₹6.00 M Open
01 Mar 2006 The United Western Bank Limited ₹4.00 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Richfield (India) Pharmaceuiticals?

Richfield (India) Pharmaceuiticals has a workforce of 28 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Richfield (India) Pharmaceuiticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Richfield (India) Pharmaceuiticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Richfield (India) Pharmaceuiticals
Recent Activity within the Organization
  • Annual General Meeting

    Richfield (India) Pharmaceuiticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Richfield (India) Pharmaceuiticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was recorded as a recent event.

  • Charges

    The activity A charge with Others of Rs. 6.00 M registered on 15 Sep 2017 with Charge ID 100150832 was modified on 20 Mar 2019. was completed.

  • Charges

    Progress on A charge with Others amounted to Rs. 6.00 M with Charge ID 100150832 was registered on 15 Sep 2017. was documented.

  • Director Appointment

    The activity Laxmilal Bhavarlal Jain was appointed as a Managing Director was appointed as a Managing Director on 29 Aug 2007 & has been associated with this company since 18 years 6 months . was completed.

  • Director Appointment

    The activity Suman Laxmilal Jain was appointed as a Whole-time director was appointed as a Whole-time director on 29 Aug 2007 & has been associated with this company since 18 years 6 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Richfield (India) Pharmaceuiticals Private Limited?

The CIN of Richfield (India) Pharmaceuiticals Private Limited is U85110KA2005PTC037914.

Where is Richfield (India) Pharmaceuiticals Private Limited headquartered?

Richfield (India) Pharmaceuiticals Private Limited is headquartered at No.102, Cts No. 420/3A, First Floor Enkay Complex, Keshwapur, Hubballi, Karnataka, 580023.

When was Richfield (India) Pharmaceuiticals Private Limited incorporated?

Richfield (India) Pharmaceuiticals Private Limited was incorporated on 12 December 2005.

Who are the current directors of Richfield (India) Pharmaceuiticals Private Limited?

The current directors of Richfield (India) Pharmaceuiticals Private Limited are

What is the primary industry of Richfield (India) Pharmaceuiticals Private Limited?

The primary industry of Richfield (India) Pharmaceuiticals Private Limited is Trade.

Is Richfield (India) Pharmaceuiticals Private Limited a listed company?

Richfield (India) Pharmaceuiticals Private Limited is unlisted.

What is the capital structure of Richfield (India) Pharmaceuiticals Private Limited?

The authorized capital of Richfield (India) Pharmaceuiticals Private Limited is ₹0.95 M, and the paid-up capital is ₹0.91 M.

What is the compliance status of Richfield (India) Pharmaceuiticals Private Limited?

The compliance status of Richfield (India) Pharmaceuiticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available